Filtered By:
Condition: Hypertension
Nutrition: Calcium

This page shows you your search results in order of relevance. This is page number 10.

Order by Relevance | Date

Total 337 results found since Jan 2013.

Recommendations for the Treatment of Hypertension in Elderly People.
Authors: Rubio-Guerra AF, Duran-Salgado MB Abstract High blood pressure is a major cardiovascular risk factor. The prevalence of hypertension increases with aging. As a consequence of changes in arterial wall that leads to arterial stiffness, the majority of elderly patients suffer isolated systolic hypertension. The evidence strongly supports that hypertension in the elderly is associated with an increase in stroke risk and cardiovascular mortality and morbidity. Several trials have shown the benefits of treating hypertension in elderly patients. Even in the very old patients, the use of antihypertensive agents su...
Source: Cardiovascular and Hematological Agents in Medicinal Chemistry - March 12, 2015 Category: Cardiology Tags: Cardiovasc Hematol Agents Med Chem Source Type: research

Drug Therapy of Apparent Treatment-Resistant Hypertension: Focus on Mineralocorticoid Receptor Antagonists
Abstract Apparent treatment-resistant hypertension (aTRH) is defined as blood pressure (BP) >140/90 mmHg despite three different antihypertensive drugs including a diuretic. aTRH is associated with an increased risk of cardiovascular events, including stroke, chronic renal failure, myocardial infarction, congestive heart failure, aortic aneurysm, atrial fibrillation, and sudden death. Preliminary studies of renal nerve ablation as a therapy to control aTRH were encouraging. However, these results were not confirmed by the Symplicity 3 trial. Therefore, attention has refocused on drug therapy. Secondary forms o...
Source: Drugs - March 19, 2015 Category: Drugs & Pharmacology Source Type: research

HYT-Hypertension in Turkey: A Cross-Sectional Survey on Blood Pressure Control with Calcium Channel Blockers Alone or Combined with Other Antihypertensive Drugs
Conclusions Taken together these findings provide evidence that dihydropyridine-type CCBs, particularly when combined with ACE-inhibitors or angiotensin II receptors blockers, allow to achieve a blood pressure control better than the one reported in the same geographic area by other treatment strategies based on different combinations of diuretics, beta-blockers, ACE-inhibitors, angiotensin II receptors blockers and calcium channel blockers.
Source: High Blood Pressure and Cardiovascular Prevention - April 22, 2015 Category: Cardiology Source Type: research

Massive Left Ventricular Calcification
94-year-old male presented for follow-up for shortness of breath. He has a history of two episodes of anterior and inferior myocardial infarction (MI) (eight and thirteen years ago) with stent revascularization, ischemic cardiomyopathy, implantable cardioverter defibrillator, paroxysmal atrial fibrillation, hypertension, hyperlipidemia, diabetes, and stroke. Lab investigation showed normal kidney function and calcium level. Echocardiography showed a reduced left ventricular (LV) ejection fraction of 25%, diastolic dysfunction, severe anteroseptal hypokinesis, otherwise normal LV.
Source: International Journal of Cardiology - April 28, 2015 Category: Cardiology Authors: Anas Alani Tags: Letter to the Editor Source Type: research

Bradycardia caused by Intravenous Nicardipine in an Elderly Patient with Acute Ischemic Infarct
We report the case of an elderly patient with an acute ischemic stroke who developed nicardipineinduced bradycardia in the ED.
Source: The American Journal of Emergency Medicine - August 17, 2015 Category: Emergency Medicine Authors: Michael E. Abboud, Sarah E. Frasure Tags: Case Report Source Type: research

Sleep Problems May Hint At Future Heart Disease Risk
By Kathryn Doyle (Reuters Health) - Adults who get too much or too little sleep may have the beginnings of “hardening" of the arteries, which can be an early sign of heart disease, according to a new study. “Many people, up to one third or one fourth of the general population, suffer from inadequate sleep – either insufficient duration of sleep or poor quality of sleep,” said co-lead author Dr. Chan-Won Kim of Kangbuk Samsung Hospital of Sungkyunkwan University School of Medicine in Seoul, South Korea. Several studies have linked inadequate sleep with an increased risk of heart attack and stroke, bu...
Source: Healthy Living - The Huffington Post - September 10, 2015 Category: Consumer Health News Source Type: news

New therapies for arterial hypertension.
Authors: Pagliaro B, Santolamazza C, Rubattu S, Volpe M Abstract Arterial hypertension is the most common chronic disease in developed countries and it is the leading risk factor for stroke, ischemic heart disease, congestive heart failure, chronic renal failure and peripheral artery disease. Its prevalence appears to be about 30-45% of the general population. Recent European guidelines estimate that up to 15-20% of the hypertensive patients are not controlled on a dual antihypertensive combination and they require three or more different antihypertensive drug classes to achieve adequate blood pressure control. The...
Source: Panminerva Medica - January 18, 2016 Category: Journals (General) Tags: Panminerva Med Source Type: research

Therapeutic potential of chalcones as cardiovascular agents
Publication date: Available online 11 February 2016 Source:Life Sciences Author(s): Debarshi Kar Mahapatra, Sanjay Kumar Bharti Cardiovascular diseases are the leading cause of death affecting 17.3 million people across the globe and are estimated to affect 23.3 million people by year 2030. In recent years, about 7.3 million people died due to coronary heart disease, 9.4 million deaths due to high blood pressure and 6.2 million due to stroke, where obesity and atherosclerotic progression remain the chief pathological factors. The search for newer and better cardiovascular agents is the foremost need to manage cardiac p...
Source: Life Sciences - February 11, 2016 Category: Biology Source Type: research

Relationship between HRV measurements and demographic and clinical variables in a population of patients with atrial fibrillation
Abstract Little is known about the role of HRV in atrial fibrillation (AF) patients. Aim of our study was to assess the relationship between HRV measurements and demographic and clinical variables in a population of 274 AF patients. We selected all consecutive patients with persistent/permanent AF among whom had performed a Holter ECG in our Department from April 2010 to April 2015. Time-domain analysis of HRV was evaluated. Demographic and clinical variables were collected for each patient. At multivariable logistic regression, a higher pNN50 was associated with ACE inhibitors/ARBs (p = 0.016) and a lower pNN50...
Source: Heart and Vessels - March 3, 2016 Category: Cardiology Source Type: research

Summary: International Kidney Cancer Symposium
Conclusions:  Ideal ischemia time is 20-25 minutes or less improves short and long term renal function.  >25 minutes carried 5 year risk of new onset stage 4 CKD No differences on GFR for cold vs. warm ischemia times Preoperative GFR and the percent of kidney preserved was a better predictor of post op GFR.  No ischemia preserves renal function better than warm. Longer cold ischemia times were equivalent to shorter warm ischemia times. Quality and quantity of the remaining kidney is associated with ultimate renal function. Robotics in RCC Surgery Gennady Bratslavsky, MD The...
Source: Kidney Cancer Association - December 15, 2011 Category: Urology & Nephrology Source Type: news

Systematic review: antihypertensive drug therapy in patients of African and South Asian ethnicity
In conclusion, in patients of African ethnicity, treatment initiated with ACE inhibitor or angiotensin II receptor blocker monotherapy was associated with adverse cardiovascular outcomes. We found no evidence of different efficacy of antihypertensive drugs in South Asians, but there is a need for trials with morbidity and mortality outcomes. Screening for cardiovascular risk at a younger age, treating hypertension at lower thresholds, and new delivery models to find, treat and follow hypertensives in the community may help reduce the excess cardiovascular mortality in these high-risk groups.
Source: Internal and Emergency Medicine - March 29, 2016 Category: Emergency Medicine Source Type: research

Coronary artery calcium scores and cardiovascular risk factors in 31,545 asymptomatic Korean adults
Abstract The aims of this study were to identify the distribution of coronary artery calcium score (CACS) by age group and cardiovascular (CV) risk factors and to evaluate the association between CV risk factors and CACS classification in asymptomatic adults. The study included 31,545 asymptomatic Koreans, over 20 years of age with no previous history of malignancy, proven coronary artery disease, or stroke, who underwent CACS computed tomography at the Health Promotion Center, Samsung Medical Center, between January 2005 and June 2013. Mean (±SD) age was 53.8 (±8.5) years overall, 56.1 (±8.3) in men, and 53.3 ...
Source: The International Journal of Cardiovascular Imaging - April 26, 2016 Category: Radiology Source Type: research

What to do when blood test results not quite “normal”
Picture this: you’re reading the results of your recent bloodwork, and you notice some numbers are teetering on the edge of the normal range. Should you be concerned? “It’s tricky, because in some tests, a borderline result makes no difference. In others, it might indicate an important change in health that we need to follow or act on,” says geriatrician Dr. Suzanne Salamon, assistant professor at Harvard Medical School. About normal ranges and interpreting the numbers When you look at a printout of your lab results, you’ll find the normal ranges for each blood test next to your personal results. For example, if ...
Source: New Harvard Health Information - June 2, 2016 Category: Consumer Health News Authors: Heidi Godman Tags: Tests and procedures blood test Source Type: news

What to do when blood test results are not quite “normal”
Picture this: you’re reading the results of your recent bloodwork, and you notice some numbers are teetering on the edge of the normal range. Should you be concerned? “It’s tricky, because in some tests, a borderline result makes no difference. In others, it might indicate an important change in health that we need to follow or act on,” says geriatrician Dr. Suzanne Salamon, assistant professor at Harvard Medical School. About normal ranges and interpreting the numbers When you look at a printout of your lab results, you’ll find the normal ranges for each blood test next to your personal results. For example, if ...
Source: New Harvard Health Information - June 2, 2016 Category: Consumer Health News Authors: Heidi Godman Tags: Tests and procedures blood test Source Type: news

Renin‐Angiotensin System Inhibitors vs Other Antihypertensives in Hypertensive Blacks: A Meta‐Analysis
The purpose of this study was to assess the effects of renin‐angiotensin system (RAS) inhibitors vs other antihypertensive agents on cardiovascular outcomes in hypertensive black patients. The authors performed a systematic review and meta‐analysis of studies that compared the effects of angiotensin‐converting enzyme (ACE) inhibitors or angiotensin receptor blockers (ARBs) with calcium channel blockers (CCBs), diuretics, and β‐blockers in hypertensive black patients on cardiovascular outcomes. A total of 38,983 patients with a mean age of 60 years and mean follow‐up of 4 years were included in our meta‐analy...
Source: The Journal of Clinical Hypertension - July 3, 2016 Category: Cardiology Authors: Mohan Palla, Tomo Ando, Emmanuel Androulakis, Tesfaye Telila, Alexandros Briasoulis Tags: Original Paper Source Type: research